CapsoVision director exercises 2,022 RSUs into shares

CapsoVision, Inc director Julia S. Gouw exercised Restricted Stock Units to acquire additional common shares as part of her equity compensation.

Rhea-AI Filing Summary

CapsoVision, Inc director Julia S. Gouw exercised Restricted Stock Units to acquire additional common shares as part of her equity compensation. On 2026-06-30, she converted 2,022 RSUs into 2,022 shares of common stock, an exercise classified as a derivative conversion rather than an open-market purchase or sale.

The RSUs were originally granted on 2026-03-19 using a fair market value of $6.18 per share and vest in two equal installments on June 30 and December 31 of the applicable year. This transaction reflects the vesting of one half of the original grant and the delivery of the underlying shares. Following the transaction, Gouw directly holds 4,909 common shares and 2,023 RSUs, highlighting a compensation-driven increase in her equity stake rather than a discretionary market trade.

Insights

Equity compensation analyst

Director’s RSU vesting increased share holdings through a routine equity grant.

Director Julia S. Gouw converted 2,022 RSUs into the same number of CapsoVision common shares at a stated price of $0.00 per unit, reflecting equity compensation rather than a market purchase. The transaction is coded as an option/derivative exercise.

The footnotes state the RSUs were granted on 2026-03-19 at a fair market value of $6.18 per share and vest 50% on June 30 and 50% on December 31 each year. This report covers vesting of one-half of that grant and delivery of the underlying shares.

After the vesting, Gouw holds 4,909 common shares and 2,023 remaining RSUs, with no open-market sales reported in this filing. Given the compensation-related nature and modest scale, this looks like a routine update to her equity position rather than a thesis-changing event for shareholders.

Insider Trade Summary

2,022 shares exercised/converted

Exercise 2 txns

Insider GOUW JULIA S

Role Director

Type	Security	Shares	Price	Value
Exercise	Restricted Stock Unit (RSU)	2,022	$0.00	$0.00
Exercise	Common Stock	2,022	$7.58	$15K

Holdings After Transaction: Restricted Stock Unit (RSU) — 2,023 contracts (Direct); Common Stock — 4,909 shares (Direct)

Footnotes (2)

1. F1. Each Restricted Stock Unit (the "RSU") represents a contingent right to receive one share of the Issuer's common stock.
2. F2. The Restricted Stock Units (RSUs), the conversion of which are reported herein, were granted to the Reporting Person by the issuer as part of equity incentive grants made by the issuer on 3/19/2026 utilizing a fair market value (FMV) of a share of the issuers stock of $6.18. The RSU grant vests as to 50% of the RSUs subject to the award on June 30 of the applicable year and as to 50% of the RSUs subject to the award on December 31 of that year. This report reflects the vesting of one-half portion of the original RSU grant and the acquisition by the Reporting Person of the underlying shares.

Key Figures

RSUs exercised: 2,022 units Common shares acquired: 2,022 shares Fair market value at grant: $6.18 per share +2 more

5 metrics

RSUs exercised 2,022 units RSUs converted to common stock on June 30, 2026

Common shares acquired 2,022 shares Shares received from RSU conversion on June 30, 2026

Fair market value at grant $6.18 per share FMV used for RSU grant on March 19, 2026

Shares held after transaction 4,909 shares Director’s direct common stock holdings following RSU vesting

Remaining RSUs 2,023 units Unvested or unconverted RSUs after June 30, 2026 event

Key Terms

Restricted Stock Unit (RSU), equity incentive grants, fair market value (FMV), derivative exercise/conversion

4 terms

Restricted Stock Unit (RSU) financial

"Each Restricted Stock Unit (the "RSU") represents a contingent right to receive one share"

A restricted stock unit (RSU) is a promise from a company to give an employee company shares (or cash equal to their value) at a future date if certain conditions are met, such as staying with the company or hitting performance targets. For investors, RSUs matter because when they convert into actual shares they increase the number of shares available and can create selling pressure as employees cash out—think of them as a future paycheck paid in company stock.

equity incentive grants financial

"were granted to the Reporting Person by the issuer as part of equity incentive grants made"

fair market value (FMV) financial

"utilizing a fair market value (FMV) of a share of the issuers stock of $6.18"

derivative exercise/conversion financial

"transaction_action": "derivative exercise/conversion""

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did CapsoVision (CV) report for director Julia S. Gouw?

CapsoVision reported that director Julia S. Gouw exercised 2,022 Restricted Stock Units into 2,022 common shares. The transaction was a derivative conversion related to equity compensation, not an open-market purchase or sale of CapsoVision stock.

How many CapsoVision (CV) shares does Julia S. Gouw hold after this Form 4?

After the reported transactions, Julia S. Gouw directly holds 4,909 shares of CapsoVision common stock. She also retains 2,023 Restricted Stock Units, which represent the right to receive an equal number of additional common shares in the future.

What is the origin and vesting schedule of the RSUs in this CapsoVision (CV) filing?

The RSUs were granted on March 19, 2026, using a fair market value of $6.18 per share. They vest 50% on June 30 and 50% on December 31 of the applicable year, making this Form 4 the record of one half of that grant vesting.

Did the CapsoVision (CV) Form 4 show any insider share sales by Julia S. Gouw?

No share sales were reported. The Form 4 shows a derivative exercise of 2,022 RSUs into common stock, increasing Gouw’s direct share ownership. There are no open-market sale transactions or tax-withholding dispositions in this specific filing.

How are the CapsoVision (CV) RSUs described in the Form 4 footnotes?

Each Restricted Stock Unit represents a contingent right to receive one share of CapsoVision common stock. The footnotes explain that the RSUs come from an equity incentive grant and that this filing reflects the vesting of one-half of the original RSU grant.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 07/01/2026 - 08:17 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

GOUW JULIA S

(Last) (First) (Middle)

C/O CAPSOVISION, INC.

18805 COX AVENUE, SUITE 250

(Street)

SARATOGA CALIFORNIA 95070

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
CapsoVision, Inc [ CV ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/30/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock(1)	06/30/2026		M		2,022	A	$7.58	4,909	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Unit (RSU)	$0	06/30/2026		M			2,022	(2)	(2)	Common Stock	2,022	$0	2,023	D

Explanation of Responses:

1. Each Restricted Stock Unit (the "RSU") represents a contingent right to receive one share of the Issuer's common stock.

2. The Restricted Stock Units (RSUs), the conversion of which are reported herein, were granted to the Reporting Person by the issuer as part of equity incentive grants made by the issuer on 3/19/2026 utilizing a fair market value (FMV) of a share of the issuers stock of $6.18. The RSU grant vests as to 50% of the RSUs subject to the award on June 30 of the applicable year and as to 50% of the RSUs subject to the award on December 31 of that year. This report reflects the vesting of one-half portion of the original RSU grant and the acquisition by the Reporting Person of the underlying shares.

Remarks:

	/s/ Kang-Huai (Johnny) Wang, Attorney-in-Fact for Julia S. Gouw	07/01/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)